Signal transduction through Ras-GTPase and Ca2+/calmodulin- dependent protein kinase II contributes to development of diabetes-induced renal vascular dysfunction

Cell Biochemistry and Function

Volumn 24, Issue 4, 2006, Pages 299-305

  Yousif, Mariam H M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Angiotensin; CaMKII; Endothelin; KN 93; Norepinephrine; Renal artery

Indexed keywords

ANGIOTENSIN II; CARBACHOL; ENDOTHELIN 1; GLUCOSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HISTAMINE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; STREPTOZOCIN; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; RENOVASCULAR DISEASE; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; FEMALE; GTP PHOSPHOHYDROLASES; PHOSPHONIC ACIDS; RAS PROTEINS; RATS; RATS, WISTAR; RENAL ARTERY; SIGNAL TRANSDUCTION; STREPTOZOCIN; VASOCONSTRICTION; VASODILATION;

ANIMALIA;

EID: 33745980207     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1301     Document Type: Article

References (39)

1. Garcia MJ, McNamara PM, Gordon T. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow up study. Diabetes 1974; 23: 105-111.
2. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 1989; 5: 547-558.
3. 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 1990; 16: 239-248.
4. Mayhan WG, Irvine SD, Sharpe GM. Constrictor responses of resistance arterioles during diabetes mellitus. Diabetes Res Clin Pract 1999; 44: 147-156.
5. Oyama Y, Kawasaki H, Hattori V, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986; 132: 75-78.
6. Kamata K, Miyata N, Kasuya Y. Impairement of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 1989; 97: 614-618.
7. Makino A, Ohuchi K, Kamata K. Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol 2000; 13: 549-556.
8. Muthalif M, Karzoun N, Benter IF, et al. Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II-induced vascular hyperplasia and hypertension. Hypertension 2002; 39: 704-709.
9. 2+/calmodulin-dependent protein kinase II (CaMKII) isoforms in human beta cells. Diabetologia 2000; 43: 465-473.
10. Aschcroft SJ. Protein phosphorylation and beta-cell function. Diabetologia 1994; 37: S21-S29.
11. Osterhoff M, Mohlig MM, Ortmann J, Bikashagi F, Schatz H, Pfeiffer A. Antisense-RNA supression of Ca++/calmodulin dependent protein kinase Iid2 (CaMK II) in INS-1 cells causes a loss of insullin, GLUT-2, glukokinase, and IAPP gene expression. Diabetologia 1999; 42: A25 (abstract).
12. Bhardwaj SK, Kaur G. Effect of diabetes on calcium/calmodulin dependent protein kinase-II from rat brain. Neurochem Int 1999; 35: 329-335.
13. Muthalif MM, Benter IF, Khandekar Z, et al. Contribution of Ras-GTPase GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt- induced hypertension. Hypertension 2000; 35: 457-463.
14. Muthalif MM, Karzoun NA, Gaber L, et al. Ang II-induced hypertension: contribution of Ras-GTPase GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000; 36: 604-609.
15. Muthalif MM, Renter IF, Karzoun N, et al 20-Hydroxyeico-satetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 1998; 95: 12701-12706.
16. Yousif MH, Benter IF, Akhtar S. Inhibition of calcium/ calmodulin-dependent protein kinase II normalizes diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Auton Autacoid Pharmacol 2003; 23(1): 27-33.
17. Yousif MHM. Role of protein kinases in mediating diabetes-induced augmented vasoconstriction to endothelin-1 in the renal arteries of STZ-diabetic rats. Cell Biochem Funct 2005; (in press).
18. Benter IF, Yousif MHM, Hollins AJ, Griffiths SM, Akhtar S. Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase. J Vasc Res 2005; 42: 284-291.
19. Yousif MHM, Benter IF, Abraham S, Akhtar S. Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Med Princ Pract 2004; 13: 57-62.
20. Suzen S, Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Curr Med Chem 2003; 10: 1329-1352.
21. Feener EP, King GL. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit 2001; 1: 74-82.
22. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK. Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells. FASEB J 2003; 17: 417-425.
23. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622.
24. Xu D, Kyriakis JM. Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J Biol Chem 2003; 278: 39349-39355.
25. Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH. Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cell Biol 1996; 16: 3707-3713.
26. Gulbins E, Coggeshall KM, Brenner B, Schlottmann K, Linderkamp O, Lang F. Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway. J Biol Chem 1996; 18(271): 26389-26394.
27. Cuda G, Paterno R, Ceravolo R, et al. Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 2002; 105: 968-974.
28. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 2004; 53: 775-783.
29. Kim I, Je HD, Gallant C, et al. Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol 2000; 526: 367-374.
30. Rokolya A, Singer HA. Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am J Physiol Cell Physiol 2000; 278: C537-C545.
31. Bhardwaj SK, Kaur G. Effect of diabetes on calcium/calmodulin dependent protein kinase-II from rat brain. Neurochem Int 1999; 35: 329-335.
32. Pauly RR, Bilato C, Sollott SJ, et al. Role of calcium/calmodulin- dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 1995; 91: 1107-1115.
33. Natarajan R, Scott S, Bai W, Yerneni KK, Nadler J. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 1999; 33: 378-384.
34. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase C beta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 2002; 90: 107-111.
35. Kassab E, McFarlane SI, Sowers JR. Vascular complications in diabetes and their prevention. Vasv Med 2001; 6: 249-255.
36. Beenen O, Mathy MJ, Pfaffendorf M, van Zwieten PA. Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J Hypertens 1996; 14: 1125-1130.
37. Dai FX, Diederich A, Skopec J, Diederich D. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Amer Soc Nephrol 1993; 4: 1327-1336.
38. Alabadi JA, Miranda FJ, Llorens S, de Apodaca R, Centeno J. Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries. Eur J Pharmacol 2001; 415: 225-232.
39. Arikawa E, Verma S, Dumont AS, McNeill JH. Chronic bosentan treatment improves renal artery vascular function in diabetes. J Hypertens 2001; 19: 803-812.